Zydus Lifesciences just delivered a spectacular FY24 with record-breaking profits and a historic $1 …
Zim Laboratories’ Q1FY25 results reveal more than just numbers; they signal a major strategic …
Cipla just reported a stellar FY2024, crossing the ₹25,000 crore revenue mark with a massive 47% …
Zydus Lifesciences reported a stellar Q1 FY25, shattering expectations with a nearly 35% profit …
Anuh Pharma’s latest Q1 FY26 earnings reveal a captivating paradox: soaring revenue contrasted …
Granules India’s Q1 FY26 results reveal a fascinating blend of strategic expansion and …
Zydus Lifesciences’ Q1 FY26 earnings show modest growth, but beneath the surface lies a …
Alkem Laboratories’ Q1 FY26 results reveal a pharma giant outperforming in India while …
Cohance Lifesciences’ latest earnings report presents a complex picture of growth. Discover …
Aarti Pharmalabs’ Q1 FY26 consolidated results appear alarming, but they hide a powerful …
Marksans Pharma’s Q1 FY'26 earnings showed a notable profit decline, but a deeper dive reveals …
Unlock the secrets behind Shilpa Medicare’s surprising 1QFY26 financial results. Despite …
Anthem Biosciences kicked off FY26 with robust revenue and profitability, driven by its CRDM …
Don’t let GMM Pfaudler’s Q1 FY26 Profit After Tax (PAT) fool you. While headline numbers …
While Akums Drugs and Pharmaceuticals’ Q1 FY26 revenue growth appears modest, a deeper dive …
Innova Captab’s Q1 FY26 earnings reveal robust revenue growth, fueled by a standout …
Discover how GSK Pharma defied expectations in Q1 FY26, turning flat revenue into a stunning profit …
Uncover the impressive details of Sequent Scientific’s Q1 FY26 results. Learn how robust …
Amidst broader market corrections, OneSource Specialty Pharma’s Q1 FY ‘26 results signal …
Alembic Pharma kicked off FY26 with mixed yet encouraging Q1 results. This analysis delves into the …
Zim Laboratories reported a challenging Q1 FY26, with profits plummeting due to geopolitical …
SMS Pharmaceuticals delivered a compelling Q1 FY26, showcasing double-digit revenue and profit …
Gufic Biosciences’ Q1 FY26 results reveal healthy revenue growth but a noticeable dip in …
Amidst broader market corrections, Eris Lifesciences’ Q1 FY26 results stand out. Discover how …
Medicamen Biotech just released its Q1 FY25 results, showing a stark swing from profit to …
Biocon’s Q1 FY26 earnings present a nuanced picture. While headline profits dipped, this …
Concord Biotech’s Q1FY26 results presented a puzzling dip in revenue and EBITDA. Is this cause …
Caplin Point Laboratories has released its Q1 FY26 earnings call transcript. This article delves …
Mangalam Drugs And Organics Limited’s Q1 FY26 results reveal a shocking financial reversal. …
Gland Pharma’s Q1 FY26 results show a powerful rebound, with profits soaring by 50% and its …
Medicamen Biotech’s Q1 FY26 results are in, revealing a complex financial picture. While …
Aurobindo Pharma’s Q1 FY26 results present a complex picture. While profitability faced …
Cohance Lifesciences’ Hyderabad facility completed a USFDA inspection, receiving 6 …
Amidst broader market corrections, Acutaas Chemicals’ Q1 FY26 earnings unveil a story of …
Senores Pharmaceuticals’ Q1FY26 results are turning heads with impressive growth across key …
Indoco Remedies’ Q1 FY26 earnings signal the initial stages of a recovery, showing sequential …
Lupin has inked a strategic License and Supply Agreement with Zentiva to commercialize its …
Torrent Pharmaceuticals Limited has announced a mandatory open offer to acquire an additional 26.00% …
Torrent Pharmaceuticals Limited has announced a significant move to acquire a controlling stake in …
Alembic Pharmaceuticals Limited (APLLTD) announced on June 29, 2025, that it has received final …